Suggested table of clinical case studies (to include in article): columns for patient phenotype (age, BMI, diagnosis), peptide used (dose, duration), metabolic outcomes (weight change, HOMA-IR), reproductive outcomes (ovulation, oocyte yield, pregnancy), adverse events, and follow-up duration, such as PCOS, obesity-associated anovulation, poor ovarian response, and metabolic syndrome
Knowing which ones to take for your specific situation is what actually solves the problem
Many of the properties and benefits sought by GLP-1 users have wider appeal and could set the tone for healthy NPD for the foreseeable future
Women considering affordable tirzepatide options may find that the switch addresses both cost and sexual side effect concerns